BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1188 related articles for article (PubMed ID: 6383412)

  • 1. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies].
    Delsol G; Al Saati T; Caveriviere P; Voigt JJ; Ancelin E; Rigal-Huguet F
    Ann Pathol; 1984; 4(3):165-83. PubMed ID: 6383412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections.
    Marder RJ; Variakojis D; Silver J; Epstein AL
    Lab Invest; 1985 May; 52(5):497-504. PubMed ID: 3887032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
    Epstein AL; Marder RJ; Winter JN; Fox RI
    J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues.
    Cartun RW; Coles FB; Pastuszak WT
    Am J Pathol; 1987 Dec; 129(3):415-21. PubMed ID: 3322020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
    Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
    Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
    Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ immunologic characterization of follicular lymphomas.
    Ancelin E; Delsol G; Familiades J; Mason DY; Kuhlein E; Al Saati T; Laurent G; Huguet-Rigal F
    Hematol Oncol; 1984; 2(3):221-37. PubMed ID: 6384007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
    Pinkus GS; Thomas P; Said JW
    Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells.
    Imam A; Stathopoulos E; Holland SL; Epstein AL; Taylor CR
    Cancer Res; 1990 Mar; 50(5):1650-7. PubMed ID: 1689214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The demonstration of B-cell, T-cell and myeloid antigens in paraffin sections.
    West KP; Warford A; Fray L; Allen M; Campbell AC; Lauder I
    J Pathol; 1986 Oct; 150(2):89-101. PubMed ID: 3540244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Hodgkin's lymphomas: an immunohistochemical and histological study.
    Curran RC; Jones EL
    J Pathol; 1979 Dec; 129(4):179-90. PubMed ID: 317105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunochemical diagnosis of hepatic localizations in malignant lymphoid hematologic diseases. Study of 80 cases].
    Voigt JJ; Vinel JP; Caverivière P; Pradère B; Chittal S; al Saati T; Calès P; Delsol G
    Gastroenterol Clin Biol; 1989 Apr; 13(4):343-52. PubMed ID: 2661293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.
    Aichinger G; Fill H; Wick G
    Lab Invest; 1985 Feb; 52(2):132-40. PubMed ID: 3881622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of two monoclonal antibodies (FB1 and FB21) useful for the identification of human B lymphocytes in formalin-fixed, paraffin-embedded tissues.
    Nozawa Y; Abe M; Ohno H; Fukuhara S; Wakasa H
    J Pathol; 1994 Aug; 173(4):347-54. PubMed ID: 7965394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections.
    Poppema S; Hollema H; Visser L; Vos H
    Am J Pathol; 1987 Jun; 127(3):418-29. PubMed ID: 3296769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotyping of non-Hodgkin's lymphomas using a panel of antibodies on paraffin-embedded tissues.
    Davey FR; Gatter KC; Ralfkiaer E; Pulford KA; Krissansen GW; Mason DY
    Am J Pathol; 1987 Oct; 129(1):54-63. PubMed ID: 3310651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
    Timens W; Visser L; Poppema S
    Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
    Howard DR; Eaves AC; Takei F
    Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.